# Clinical Observation of Recombinant Human Growth Hormone Injection Assisted IVF-ET in the Treatment of PCOS

> **NCT02801565** · NA · UNKNOWN · sponsor: **Changchun GeneScience Pharmaceutical Co., Ltd.** · enrollment: 208 (estimated)

## Conditions studied

- Polycystic Ovary Syndrome

## Interventions

- **DRUG:** Conventional controlled ovarian stimulation proctol

## Key facts

- **NCT ID:** NCT02801565
- **Lead sponsor:** Changchun GeneScience Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-02
- **Primary completion:** 2017-02
- **Final completion:** —
- **Target enrollment:** 208 (ESTIMATED)
- **Last updated:** 2016-11-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02801565

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02801565, "Clinical Observation of Recombinant Human Growth Hormone Injection Assisted IVF-ET in the Treatment of PCOS". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02801565. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*